Showing 2221-2230 of 3134 results for "".
- Vaginal Laser Treatment Shows Promise in Treating OABhttps://modernaesthetics.com/news/vaginal-laser-treatment-shows-promise-in-treating-oab/2473368/Vaginal laser surgery may be effective in treating overactive bladder syndrome (OAB), according to a study in Menopause. Erbium: Yttrium-Aluminum-Garnet (Erbium YAG) vaginal laser treatment is already used to treat various symptoms of the genitourinary syndrome of menopause, vagina
- Business News: BeautyHealth Buys SkinStylushttps://modernaesthetics.com/news/business-news-beautyhealth-buys-skinstylus/2473366/The Beauty Health Company is set to acquire SkinStylus, a US Food and Drug Adminstrayion -cleared microneedling device. The agreement represents a key step forward in BeautyHealth’s portfolio build-up strategy. Upon successful integration of SkinStylus into the BeautyHealth
- Hydrafacial X Omorovicza Announce Launch of Advanced Skin Renewal Boosterhttps://modernaesthetics.com/news/hydrafacial-x-omorovicza-announce-launch-of-advanced-skin-renewal-booster/2473364/The Beauty Health Company’s Hydrafacial is rolling out a new booster co-created with Hungarian skincare brand Omorovicza. The booster, available immediately to Hydrafacial providers in North America and EMEA, leverages Omorovicza’s patented Healing Concentrate for a mo
- CoolHealth Rolls Out TargetCool for Post-Procedure Pain Controlhttps://modernaesthetics.com/news/coolhealth-rolls-out-targetcool-for-post-procedure-pain-controlmo/2473359/CoolHealth is entering the U.S. market with TargetCool. Leveraging tuneable cooling technology, TargetCool rapidly cools the skin, allowing providers to specifically set a “target” skin temperature down to the exact degree and secon
- Rewards Program Launched for High-Volume AviClear Usershttps://modernaesthetics.com/news/rewards-program-launched-for-high-volume-aviclear-users/2473358/Practices in the United States and Canada using AviClear will now have access to more perks. Cutera announced that it will be launching a rewards program for AviClear practices designed to reinforce a partnership approach with practices with improved profitability, e
- Ozempic Face: A Trade-off for Significant Weight Loss?https://modernaesthetics.com/news/ozempic-face-a-trade-off-for-significant-weight-loss/2473354/It seems like everyone is taking Ozempic/Wegovy (semaglutide, Novo Nordisk) or Mounjaro (tirzepatide, Lilly) for weight loss these days, and many are reporting a side effect dubbed “Ozempic face” by the media. Facial plastic surgeons are seeing an uptick in patients concerned that rapid we
- iCRYO to Bring BTL Devices to Franchiseshttps://modernaesthetics.com/news/icryo-to-bring-btl-devices-to-franchises/2473353/iCRYO is partnering with BTL Industries to bring BTL’s suite of devices to their franchises. “We are going into a multi-year purchasing agreement to onboard several hundred devices over that time period. We are working on launching our "EMsuite" within the iC
- Game Change: Galderma Launches FACE by Galdermahttps://modernaesthetics.com/news/galderma-launches-face-by-galderma/2473349/Galderma is launching FACE by Galderma, an app that simulates the results of injectable treatments in real time using digital facial assessment. The technology was unveiled at the International Master Course on Aging Science (IMCAS) World Congress 2023 in Paris. FACE by Galder
- Study: Jeuveau “Extra-Strength” Dose Shows Lasting Resultshttps://modernaesthetics.com/news/evolus-to-present-phase-2-interim-data-from-jeuveau-extra-strength-dose-for-extended-duration-study-at-2023-imcas-world-congress/2473346/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- Juvederm Volux XC for Jaw Definition Is Herehttps://modernaesthetics.com/news/juvederm-volux-xc-for-jaw-definition-is-here/2473344/Allergan Aesthetics' Juvéderm Volux XC is now available at aesthetic practices nationwide. The filler is approved for patients older than 21 with moderate to severe loss of jawline definition. "With 40% of aesthetically-aware consumers considering tre